Pilot study of concurrent 5-fluorouracil/paclitaxel plus radiotherapy in patients with carcinoma of the esophagus and gastroesophageal junction

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 24, Issue 1, 2001, Pages 91-95

  Schnirer, Isac I ^a   Komaki, Ritsuko ^a   Yao, James C ^a   Swisher, Stephen ^a   Putnam, Joe ^a   Pisters, Peter W T ^a   Roth, Jack A ^a   Ajani, Jaffer A ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chemoradiotherapy; Combined modality therapy; Fluorouracil; Paclitaxel; Radiation therapy; Toxicity; Upper GI cancers

Indexed keywords

CIMETIDINE; DEXAMETHASONE; DIPHENHYDRAMINE; FLUOROURACIL; PACLITAXEL;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG RESPONSE; DYSPHAGIA; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; LOWER ESOPHAGUS SPHINCTER; MALE; NAUSEA; PILOT STUDY; PREMEDICATION; RADIATION DOSE; TREATMENT OUTCOME; VOMITING; WEIGHT REDUCTION;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PILOT PROJECTS; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY;

EID: 0035117166     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200102000-00018     Document Type: Article

References (23)

1. Cancer statistics, 1999
2. Current status of new drugs and multidisciplinary approaches in patients with carcinoma of the esophagus
3. Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus
4. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma
5. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma
6. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus
7. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An intergroup study
8. Activity of Taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus
9. Phase II study of Taxol in patients with advanced gastric carcinoma
10. Combined-modality therapy for esophageal cancer: Phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy
11. Paclitaxel, carboplatin, and long-term continuous 5-fluorouracil infusion in the treatment of upper aerodigestive malignancies: Preliminary results of phase II trial
12. Neoadjuvant paclitaxel, cisplatin and radiation for esophageal carcinoma: A phase II study
13. Neoadjuvant paclitaxel, cisplatin and radiation for esophageal cancer
14. Preoperative therapy with paclitaxel, carboplatin, 5FU and radiation in the treatment of local esophageal cancer
15. Phase I trial of combined modality therapy for localized esophageal cancer: Radiation therapy + concurrent cisplatin and escalating doses of 96 hour infusional paclitaxel
16. Paclitaxel (T) combined with 5-fluorouracil (FU) and cisplatin (P) concomitant with radiotherapy (RT) in locally advanced or metastatic esophageal cancer - Preliminary report of phase I/II trials
17. Phase I/II neoadjuvant concurrent 96 hour Taxol, cisplatin, and radiation therapy. Promising toxicity profile and response in localized esophageal cancer
18. Preoperative Taxol-based chemotherapy (CT) followed by chemoradiation therapy (CTRT) in patients (PTS) with potentially resectable esophageal carcinoma (EC)
19. NCCN practice guidelines for upper gastrointestinal carcinomas
20. Taxol: A novel radiation sensitizer
21. Investigation of Taxol as a potential radiosensitizer
22. Taxol sensitizes human ovarian cancer cells to radiation
23. Cyclic x-ray response in mammalian cells in vitro